A randomized, double-blind, placebo-controlled study of the safety and tolerability of high-dose quetiapine in patients with persistent symptoms of schizophrenia or schizoaffective disorder.
about
Quetiapine fumarate for the treatment of multiple sclerosis: focus on myelin repair.Treatment of early non-response in patients with schizophrenia: assessing the efficacy of antipsychotic dose escalation.Case reports of patients with treatment-resistant schizophrenia and related psychotic disorders intolerant to clozapine responding to high doses of quetiapine.Weight gain and antipsychotics: a drug safety review.Prolonged, self-administration of ultra-high doses of quetiapine.Common use of high doses of antipsychotic medications in older Asian patients with schizophrenia (2001-2009).
P2860
A randomized, double-blind, placebo-controlled study of the safety and tolerability of high-dose quetiapine in patients with persistent symptoms of schizophrenia or schizoaffective disorder.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
A randomized, double-blind, pl ...... a or schizoaffective disorder.
@en
type
label
A randomized, double-blind, pl ...... a or schizoaffective disorder.
@en
prefLabel
A randomized, double-blind, pl ...... a or schizoaffective disorder.
@en
P2093
P356
P1476
A randomized, double-blind, pl ...... a or schizoaffective disorder.
@en
P2093
Alain Gendron
Alain Labelle
G William MacEwan
Hans Eriksson
Richard Williams
STACK Study Group
William G Honer
P356
10.4088/JCP.10M06194
P577
2011-06-14T00:00:00Z